HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | June 2015 |
End Date: | March 2016 |
Contact: | Efrat Aharonovich, PhD |
Email: | ea2017@columbia.edu |
Phone: | 646-7747954 |
HealthCall: Brief Intervention to Reduce Drug Use in HIV Primary Care
This pilot study goal is to compare two different treatments to help HIV positive patients
reduce their concurrent drinking and non-injection drug use.
reduce their concurrent drinking and non-injection drug use.
The goal of this study is to compare the effects of brief motivational interviewing with
participation in HealthCall to brief motivational interviewing alone on non-injection drug
and alcohol use. HealthCall involves 2-3 minutes of daily smartphone use to track drug use,
drinking behaviors and other aspects of health, followed by personalized feedback in a graph
after 30 and 60 days of using the smartphone.
participation in HealthCall to brief motivational interviewing alone on non-injection drug
and alcohol use. HealthCall involves 2-3 minutes of daily smartphone use to track drug use,
drinking behaviors and other aspects of health, followed by personalized feedback in a graph
after 30 and 60 days of using the smartphone.
Inclusion Criteria:
Age 18 and older; 2. During the prior 30 days, > 4 days of non-injection of cocaine,
methamphetamine or heroin, one of which is identified by the patient as his/her primary
drug During prior 30 days, > 1 day of binge drinking (>4 drinks on one occasion);
Completion of medically supervised detoxification if such detoxification is required; HIV
Positive ; Able to give informed consent
Exclusion Criteria:
Patient is currently psychotic, suicidal, or homicidal. Patient has injected any drug in
the last 6 months Patient has definite plans to leave the greater New York metropolitan
area within the study period.
Patient has gross cognitive/psychomotor impairment as evidenced on the Halstead-Reitan
Trails (A+B) Patient does not speak English or Spanish Patient has a hearing and/or vision
impairment that precludes smartphone use.
We found this trial at
1
site
1051 Riverside Dr
New York, New York 10032
New York, New York 10032
646-774-5000
Phone: 646-774-7954
New York State Psychiatric Institute The New York State Psychiatric Institute (NYSPI), established in 1895,...
Click here to add this to my saved trials